Media kit
AI Tools Lab.
A faceless, evidence-led publication about AI, SaaS, developer, automation and productivity tools.
Editorial proposition
Useful AI tools, tested instead of hyped. Coverage prioritizes direct demonstrations, same-task comparisons, reproducible workflows, pricing and licensing trade-offs, and explicit disclosure of commercial relationships.
Audience
Primary language: English. Initial editorial relevance: global English-speaking buyers, especially the United States, United Kingdom, Canada, Australia and Europe.
Coverage
Evidence-led product evaluations
Direct testing where practical, with limitations and better-fit alternatives.
Same-task A/B tests
Products evaluated against the same input, job and constraints.
Practical implementation
Workflows readers can reproduce instead of generic tool lists.
Decision frameworks
Cost, licensing, setup burden and use-case fit.
Editorial capability
Coverage focuses on reproducible product workflows, implementation details, software economics and evidence that a reader can inspect. The brand does not use a personal creator identity as its public proposition.
Distribution model
Owned web articles are designed to pair with original short-form demonstrations on TikTok, Instagram Reels and YouTube Shorts, with selected long-form YouTube tutorials/reviews and professional adaptations where relevant. Distribution channels are not represented as active audience assets until they are actually public and active.
Current performance data
| Metric | Current public claim |
|---|---|
| Historical site traffic | Not claimed — launch stage |
| Social followers | Not claimed until active/public profiles exist |
| Affiliate revenue | No historical revenue claimed |
| Paid traffic | None claimed |
| Editorial geography | Global English-speaking audience; target relevance includes US, UK, Canada, Australia and Europe |
Partnership standard
Product access, affiliate terms or sponsorship can be considered when relevant to the audience. Material relationships are disclosed. Positive coverage is never guaranteed in exchange for access or commission.